1. Home
  2. SBCF vs CPRX Comparison

SBCF vs CPRX Comparison

Compare SBCF & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SBCF

Seacoast Banking Corporation of Florida

HOLD

Current Price

$30.53

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$31.24

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBCF
CPRX
Founded
1926
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.4B
IPO Year
2009
2006

Fundamental Metrics

Financial Performance
Metric
SBCF
CPRX
Price
$30.53
$31.24
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$38.00
$35.00
AVG Volume (30 Days)
810.8K
3.2M
Earning Date
04-28-2026
05-11-2026
Dividend Yield
2.43%
N/A
EPS Growth
10.56
28.24
EPS
0.29
0.50
Revenue
N/A
$119,072,803.00
Revenue This Year
$45.04
$9.20
Revenue Next Year
$6.30
$10.51
P/E Ratio
$105.09
$62.57
Revenue Growth
N/A
16.39
52 Week Low
$24.46
$19.05
52 Week High
$35.55
$32.56

Technical Indicators

Market Signals
Indicator
SBCF
CPRX
Relative Strength Index (RSI) 46.75 72.98
Support Level $29.26 $22.24
Resistance Level $32.23 $31.29
Average True Range (ATR) 0.72 0.31
MACD -0.02 -0.13
Stochastic Oscillator 43.58 95.59

Price Performance

Historical Comparison
SBCF
CPRX

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company. The company provides integrated financial services, including commercial and consumer banking, wealth management, and mortgage and insurance services, to customers across Florida through branch, mobile, and online banking solutions. It maintains day-to-day operations, particularly in the areas of operations, treasury management systems, information technology, and security. The company has one reportable segment that provides these integrated financial services, with segment revenues driven mainly by interest and fees on loans, interest on cash and cash equivalents, and investment securities, and fees on depository products and services.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: